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Renal failureMyoclonic status epilepticus (MSE) is deﬁned as prolonged period of myoclonic jerks that are correlated with
epileptiform discharges on EEG. We here describe clinical features and video-EEG records of six adult patients
with MSE who did not have a prior diagnosis of epilepsy. In four out of six patients, MSE was precipitated by
drugs. Two out of four patients had chronic renal disease and received beta lactam group antibiotics. Two
other patients, who described chronic pain, developed MSE while taking pregabalin. One patient who had
dementia and family history of juvenile myoclonic epilepsy (JME) developed MSE onemonth after quetiapine
was introduced. Another patient, who had a recent ischemic stroke, developedMSE due to an unknown reason.
In these last two patients, an immediate triggering factorwas not evident. Myoclonic status epilepticus ceased in
ﬁve out of six patients afterwithdrawal of the drugs and/or intravenous antiepileptic treatment.Myoclonic status
epilepticus is a rare event in patients without epilepsy. A correct diagnosis and prompt drug discontinuationmay
reverse this severe and life-threatening condition.
© 2012 The Authors. Published by Elsevier Inc.Open access under CC BY-NC-SA license.1. Introduction
Myoclonic status epilepticus is deﬁned as a condition inwhich gener-
alized myoclonic jerks are repeated continuously or occur in clusters
lasting for a sufﬁciently long period, usually >30 min [1]. Myoclonic sta-
tus epilepticus has been described in generalized epilepsy syndromes,
neurodegenerative diseases, toxic–metabolic states, and following anox-
ic brain injury [2,3]. It is most often seen in patients with insufﬁciently
controlled juvenile myoclonic epilepsy (JME), Dravet syndrome, and in
nonprogressive myoclonic epilepsy in infancy, particularly Angelman
syndrome [3,4]. In patients with no history of epilepsy, MSE was rarely
reported as single case reports, which were mostly drug related [5–7].
We here describe clinical features and video-EEG records, of 6 adult
patients with MSE who did not have a prior diagnosis of epilepsy. They
were followed up and treated at the Department of Neurology, Ege Uni-
versity Faculty of Medicine, between 2009 and 2011.
2. Case reports
2.1. Patient 1
An 84-year-old man was admitted with hand tremor and jerking
movements lasting for 20 days. Past medical history included mildedicine, Neurology Department,
rac).
nc.Open access under CC BY-NC-SA licdementia and type-2 diabetes mellitus. One month earlier, quetiapine
75 mg/daywas initiated for delusions and sleep problems. On admission,
he was cooperative and exhibited continuous irregular myoclonic jerks
mostly of the trunk and upper extremities. His brain magnetic resonance
imaging (MRI) scans showed cerebral atrophy. Serum chemistry and
blood count were within normal limits. The video-EEG (V-EEG) re-
vealed a well-organized background activity and very frequent bursts
of rapid generalized poly-spikes lasting 1–3 s which ceased after intra-
venous (i.v.) diazepam (up to 10 mg) (Figs. 1A–B). Treatment with
levetiracetam 1000 mg/day was introduced and quetiapine was
discontinued. A second EEG after six days revealed a nearly normal
recordingwithout evidence of epileptiform discharges. Interestingly,
a few months later, his 25-year-old grandson was diagnosed with
JME.2.2. Patient 2
A 78-year-old man presented with irregular generalized clonic-
twitching movements for more than one week. He had a history of
atrial ﬁbrillation and venous insufﬁciency. His brainMRI scan revealed
cerebral atrophy, multifocal chronic ischemic lesions, and subacute is-
chemic infarct on the left frontoparietal area. Laboratory test results
werewithin normal limits. The V-EEG showed a normal background ac-
tivity with high-amplitude, 5- to 15-Hz rapid bursts of generalized
poly-spikes synchronous with themyoclonia which normalized rapidly
after administration of i.v. diazepam (up to 10 mg). The patient
remained seizure free and did not report any myoclonia for a follow-up
of 1 year under the treatment with levetiracetam 1500 mg/day (see
Video sequence 1).ense.
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A 52-year-oldmanwas hospitalized for gastric variceal bleeding and
treated with sclerotherapy. He had a history of renal transplantation
9 years earlier andwas receiving hemodialysis for chronic renal disease.
Postoperatively, i.v. ceftriaxone and metronidazole were added to his
treatment for infection prophylaxis. Three days later, he developed con-
fusion and disorientation. The next day, continuous high-amplitude
jerking of the trunk and the extremities appeared which was followed
by series of generalized tonic-clonic seizures without full recovery of
consciousness in between. His laboratory tests were normal except for
an increase in serum creatinine and urea levels (BUN 120 mg/dl, creat-
inine 6.3 mg/dl). The brain MRI scan was unremarkable. Antibiotic
therapy was discontinued. Intravenous diazepam infusion (up to
20 mg) did not cause any clinical improvement. Subsequently, i.v.
valproic acid (2000 mg/24 h) was administrated. A V-EEG, which was
performed 24 h later, showed slowing of background rhythm and
high-voltage generalized spike-and-wave discharges (GSWD)
which were associated with generalized myoclonia. During intermit-
tent photic stimulation (IPS), violent myoclonic jerks of the eyelids,
facial muscles, and the trunk worsened (see Video sequence 2). Un-
fortunately, after a few days, the patient died due to bleeding
complications.
2.4. Patient 4
A 56-year-old woman with a diagnosis of multiple myeloma was
hospitalized for bonemarrow transplantation (BMT). She developed
continuous asynchronous myoclonic jerks mainly of the arms
and facial muscles just one day after melphalan hydrochloride
(200 mg/m2) chemotherapeutic infusion. She was treated with
pregabalin 300 mg/day for chronic pain. Her MRI scans revealed
myelomatous inﬁltration of the skull and durameter. Laboratory
test results were unremarkable. The V-EEG consisted of frequent,
5- to 10-Hz, high-amplitude, generalized spikes which lasted 1–3 s
and which were suppressed rapidly after diazepam infusion.
Pregabalin was discontinued and levetiracetam 750 mg/day was
initiated. The patient did not report myoclonia thereafter, but one
month later, she died due to BMT complications.
2.5. Patient 5
This 73-year-old woman was admitted to our neurology outpatient
clinic with left hemiparesis which occurred due to ischemic stroke
6 months earlier. She had severe burning pain on the side of the body
affected by the stroke. She had a history of dementia. Tramadol
50 mg/day and pregabalin 150 mg/day were initiated to relieve
central neuropathic pain. Three days later, she exhibited continuous
irregular generalized myoclonic jerks. Electroencephalography results
showed mild slowing of background rhythm and serial bursts of rapid
generalized spikes lasting 1–2 s. After discontinuation of pregabalin,
the clinical picture normalized rapidly.
2.6. Patient 6
This 53-year-old man was hospitalized for macroscopic hematuria
and treated with transurethral resection (TUR) of the bladder. He had
been receiving hemodialysis for chronic renal disease three times a
week for 6 years. Postoperatively, since he had fever and hypotension,
i.v. meropenem 1000 mg/day was added to his treatment. Five days
later, he developed confusion and hallucinations which were followed
by generalized myoclonia of the trunk and extremities. His laboratory
tests results were normal except for an increase in serum creatinine
and urea levels (BUN 60 mg/dl, creatinine 4.61 mg/dl). His brain CT
was unremarkable. Antibiotic therapy was discontinued. He did not re-
spond to i.v. diazepam and i.v. valproic acid infusions (2000 mg/24 h).A V-EEG was performed which showed slowing of background rhythm
and GSPW discharges. The myoclonic jerks worsened during intermit-
tent photic stimulation. His myoclonia was diminished after i.v.
levetiracetam (1500 mg/day). One week later, he was seizure free and
discharged from the hospital. Then, hewas diagnosedwith bladder can-
cer. Unfortunately, 2 months later, he died after a cystectomy due to
surgery complications.
The clinical and EEG features of the cases are summarized in Table 1.3. Discussion
Myoclonic status epilepticus is usually reported in patients with
epilepsy [4,8]. There are also case reports suggesting that it may be
associated with toxic–metabolic brain diseases or induced by drugs
in patients without epilepsy [5–7].
None of our patients had a prior diagnosis of epilepsy. Two pa-
tients developed MSE while taking pregabalin. In both, withdrawal
of the drug led to gradual resolution of the myoclonus. Pregabalin,
which is commonly used in chronic pain syndromes, can induce myo-
clonic jerks in patients with epilepsy and chronic renal failure [5,9].
Pregabalin can also induce generalized and myoclonic SE in patients
without epilepsy; however, the mechanism and frequency of this po-
tential adverse effect remain unclear [5]. Two patients had chronic
renal disease and received carbapenem and cephalosporin-type anti-
biotics which can induce a neurotoxic syndrome with encephalopa-
thy and non-rhythmic, stimulus-sensitive myoclonus, especially in
patients with renal dysfunction [10,11]. The main mechanism of
neurotoxicity appears to involve GABA-A receptor inhibition,
although other mechanisms may be possible [11]. The risk of CNS
toxicity, especially in seizures, can be increased in renal failure. Pa-
tient 1, who had dementia and family history of JME, developed
MSE one month after quetiapine was introduced. There are few re-
ports of myoclonus as an adverse effect of higher doses of
quetiapine, which interacts with broad range of neurotransmitter
receptors, including serotonergic and GABAergic systems [12];
however, we are not sure if this drug was the actual precipitating
factor for MSE.
Normal or moderately impaired consciousness and generalized
myoclonia were common presentations of our patients. In all patients,
myoclonic jerks were generalized, but predominantly affected the
upper extremities and showed some asymmetry. In four out of six pa-
tients, myoclonias were stimulus sensitive and aggravated with action.
Interestingly, in two patients with uremia, myoclonias were increased
during IPS. In other patients, this ﬁnding was not observed.
Photomyoclonic responses and sensitivity to photic stimulation have
been noted in uremic patients or renal failure [13]. However, it is rarely
reported in the English literature.
Semiology and classiﬁcation of MSE can be variable. According to
Gastaut's classiﬁcation, pure MSE was observed in patients with epi-
lepsy. Symptomatic MSE occurs as a result of infectious, inﬂammato-
ry, neurodegenerative, toxic–metabolic, or anoxic brain disease [14].
However, according to Treiman, symptomatic MSE should be consid-
ered a subtle presentation of generalized convulsive status, and the
termMSE should be used only for pure myoclonic status [15]. Our pa-
tients are considered as having symptomatic MSE according to
Gastaut's classiﬁcation.
Myoclonic status epilepticus in patients without epilepsy is a rare
event andmostly relatedwith drugs. Cognitive impairment, old age, fam-
ily history of epilepsy, and decreased creatinine clearancemaypredispose
to this condition. Precipitating drugs such as pregabalin, quetiapine,
carbapenem, and cephalosporin-type antibiotics should be avoided in
these patients. A correct diagnosis and prompt drug discontinuation
may reverse this severe and life-threatening condition.
Supplementary data related to this article can be found online at
http://dx.doi.org/10.1016/j.ebcr.2012.10.003.
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Table 1
Clinical and EEG features of the patients.
Case (sex and age) Accompanying disease Possible cause of MSE Seizure types Ictal EEG pattern Treatment of MSE (mg/day)
1 (M, 84) Dementia, DM Quetiapine
Genetic predisposition
MSE Frequent bursts of rapid generalized
spikes lasting 1–3 s
DZP (10) i.v., LEV (1000) p.o.,
quetiapine stopped
2 (M, 78) AF, subacute ischemic stroke Not found MSE Generalized, 5- to 15-Hz, high-amplitude
spikes
DZP (10) i.v., LEV (1500) p.o.
3 (M, 52) Chronic renal failure, gastric
bleeding
Ceftriaxone
Uremia
Hemodialysis
MSE
GTCS
NCSE
GPSWD, major increase of ictal activity
during IPS
VPA (2000) i.v., ceftriaxone stopped
4 (F, 56) MM, chronic pain PGB, antineoplastic
agents
MSE Generalized, frequent 5- to 10-Hz bursts
of spikes
LEV (750) p.o., PGB stopped
5 (F, 73) Ischemic stroke, dementia,
neuropathic pain
PGB MSE Rapid generalized spikes PGB stopped
6 (M, 53) Chronic renal disease,
bladder cancer
Meropenem
Hemodialysis
MSE GPSWD, major increase of ictal activity
during IPS
DZP (20) i.v., VPA (2000) i.v., LEV
(1500) i.v.
Meropenem stopped
M (Male), F (Female), DM (diabetes mellitus), AF (atrial ﬁbrillation), MM (multiple myeloma), GTCS (generalized tonic-clonic seizures), MSE (myoclonus status epilepticus), NCSE
(non-convulsive status epilepticus), GPSWD (generalized polyspike-and-wave discharges), IPS (intermittent photic stimulation), DZP (diazepam), LEV (levetiracetam), PGB (pregabalin),
VPA (valproic acid), BMT (bone marrow transplantation).
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